Problems with an influx of counterfeit medicine into Mexico from Central America are being investigated by the National Chamber of Commerce, pharmaceutical industry associations and the Mexican Attorney General's Office.
Reports from southern Mexican states - Quintana, Roo, Campeche and Yucatan, as well as Guerro in the north, have mentioned smuggling operations from outside Mexico. The Mexican health authorities have been disinclined to comment on the situation but have reportedly stepped up investigations and increased vigilance at border points.
There have been reports of smuggling in the past, but these were on a small scale and were quickly suppressed, according to the authorities. The reasons given for the influx of illegal, cheaper medicines, are thought to be the susceptibility of people to lower-priced questionable products sold in the streets and at markets.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze